Live News EQUITY L impact Jul 15, 2026, 01:34 PM UTC

MRK Merck shares climb 3% after partner kelun-biotech reports positive Keytruda lung cancer study

MRK Merck shares climb 3% after partner kelun-biotech reports positive Keytruda lung cancer study

SquawkNews Newsroom

MRK Merck shares climb 3% after partner kelun-biotech reports positive Keytruda lung cancer study